Citation and License

Abstract

Background

Over 75% of the medical devices used in India are imported. Often, they are costly
and maladapted to low-resource settings. We have prepared case studies of six firms
in Bangalore that could contribute to solving this problem. They have developed (or
are developing) innovative health care products and therefore are pioneers in the
Indian health care sector, better known for its reverse engineering skills. We have
sought to understand what enablers and barriers they encountered.

Methods

Information for the case studies was collected through semi-structured interviews.
Initially, over 40 stakeholders of the diagnostics sector in India were interviewed
to understand the sector. However the focus here is on the six featured companies.
Further information was obtained from company material and other published resources.

Results

In all cases, product innovation has been enabled by close interaction with local
medical practitioners, links to global science and technology and global regulatory
requirements. The major challenges were the lack of guidance on product specifications
from the national regulatory agency, paucity of institutionalized health care payers
and lack of transparency and formalized Health Technology Assessment in coverage decision-making.
The absence of national evidence-based guidelines and of compulsory continuous education
for medical practitioners were key obstacles in accessing the poorly regulated and
fragmented private market.

Conclusions

Innovative Indian companies would benefit from a strengthened capacity and interdisciplinary
work culture of the national device regulatory body, institutionalized health care
payers and medical councils and associations. Continuous medical education and national
medical guidelines for medical practitioners would facilitate market access for innovative
products.